Canadian Digestive Diseases
Week
January 30 to February 5, 2002,
Montreal, Quebec
 |
Meeting
Abstracts
|
|
 |
 |
|
 |
AstraZeneca
is a proud Benefactor Corporate Sponsor of
|
|
|
www.cag-acg.org
|
|
Losec® is
a proton pump inhibitor. Entocort® is a glucocorticosteroid.
Consult respective product monographs for information on patient selection,
dosing and safety.
PrLosec® and PrEntocort® are trademarks, the property
of the AstraZeneca group.
The AstraZeneca logo is a trademark of AstraZeneca PLC, used under license by
AstraZeneca Canada Inc.
Nexium® and Nexium 1-2-3 A™ are trademarks of AstraZeneca AB, used under license
by AstraZeneca Canada Inc.
